References
- Rodstein M. Heart disease in the aged. In: Rossman J. ed. Clinical geriatrics. Philadelphia: JB Lippincott 1971
- Nestico PF, Morganroth J. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment Cardiol Clin 1986: 4(2): 285–303
- Hinkle LE, Carver ST, Argyros DC. The prognostic significance of ventricular premature contractions in healthy people and people with coronary heart disease. Acta Cardiol (Suppl) (Brux) 1974: 18: 5
- Camm AJ, Evans KE, Ward DE, et aL The rhythm of the heart in active elderly patients. Am Heart J 1980: 99(5): 598–603
- Fleg JL, Kennedy HL. Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. Chest 1982: 81(3): 302–7
- Bigger JT. Definition of benign versus malignant ventricular arrhythmias: targets for treatment Am J Cardiol 1983: 52(6): 47C–54C
- Rosenthal ME, Oseran DS, Gang E, et al. Sudden cardiac death following acute myocardial infarction. Am Heart J 1985: 109(4): 865–76
- Rahimtoola SH. Are the findings from the randomized Coronary Artery Surgery Study (CASS) of value in the management of patients soon after acute myocardial infarction? Am J Cardiol 1985: 56(1): 179–81
- DeBusk RF, Blomqvist CG, Kouchoukos NT, et al. Identification and treatment of low-risk patients after acute myocardial infarction and coronary-artery bypass graft surgery. N Engl J Med 1986: 314(3): 161–6
- Theroux P. Waters DD. Halphen C. et al. Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med 1979: 301(7): 341–5
- Weld FM, Chu KL, Bigger JT, et al. Risk stratification with low-level exercise testing two weeks after acute myocardial infarction. Circulation 1981: 64(2): 306–14
- Sami M. Kraemer H. DeBusk RF. The prognostic significance of serial exercise testing after myocardial infarction. Circulation 1979: 60(6): 1238–46
- Mukharji J, Rude RE, Poole WK, et al. Risk factors for sudden death after acute myocardial infarction: two year followup. Am J Cardiol 1984: 54(1): 31–6
- Bigger JT Jr. Fleiss JL, Kleiger R, et al. The relationships among ventricular arrhythmias, left ventricular dysfunction and mortality in the 2 years after myocardial infarction. Circulation 1984: 69(2): 2508
- Furberg CD. Effect of antiarrhythmic drugs on mortality after myocardial infarction. Am J Cardiol 1983: 52(6): 32C–36C
- Pratt CM, Young JB, Roberts R. The role of beta- blockers in the treatment of patients after infarction. Cardiol Clin 1984: 2(1): 13–20
- Schaeffer WA. Cobb LA. Recurrent ventricular fibrillation and modes of death in survivors of out- of-hospital ventricular fibrillation. N Engl J Med 1975: 293(6): 259–62
- Graboys TB, Lown B, Podrid PJ, et aL Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am J Cardiol 1982: 50(3): 437–43
- Ruskin JN, DeMarco JP, Garan H. Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy. N Engl J Med 1980: 303(11): 607–13
- Swerdlow CD. Winkle RA, Mason JW. Determinants of survival in patients with ventricular tachyarrhythmias. N Engl J Med 1983: 308(24): 1436–42
- Heger JJ, Prystowaky EN, Jackman WM, et al. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med 1981: 305(10): 539–45
- Mirowaki M. The automatic implantable cardioverter-defibrillator an overview. J Am Coll Cardiol 1985: 6(2): 461–6
- Harrison DC. Antiarrhythmic drug classification: new science and practical applications. Am J Cardiol 1985: 56(1): 185–7